Boston, Massachusetts--(Newsfile Corp. - December 3, 2020) - Rich Horgan, Founder & President of Cure Rare Disease (CRD), has been recognized by 'Forbes 30 under 30' in the Healthcare category for 2021, a nod to his leadership in the groundbreaking development of customized therapeutics for those who have been diagnosed with rare, genetic diseases with no treatment or cures, starting with Duchenne muscular dystrophy (DMD).

To view the full announcement, including downloadable images, bios, and more, click here.

Key Takeaways:

• Rich Horgan, Founder & President of Cure Rare Disease, has been recognized by 'Forbes 30 under 30' in the Healthcare category for 2021
• Attributed to his leadership in the groundbreaking development of customized therapeutics for those who have been diagnosed with rare, genetic diseases.
• Out of 15,000 nominees, Forbes selected just 600 revolutionaries in 20 industries changing the course and face of business and society.

Click image above to view full announcement.

ABOUT CURE RARE DISEASE

Cure Rare Disease is transforming possibilities for people with rare neuromuscular disease by fast-tracking customized therapeutics in time to save lives. Together with a collaborative of leading researchers and clinicians, we are forging a new path to expedite individualized genetic corrections from clinical research to cure, and help patients with devastating degenerative conditions who need interventions--now. Our community of forward-thinking families, patients, scientists and supporters is moving the future of medicine to the forefront, today. Our discoveries and methods could help millions of individuals with rare diseases of all types. Cure Rare Disease is a 501 (c)(3) nonprofit based in Boston, Massachusetts. Learn more and get involved: www.cureraredisease.org.

Media Contact: Nina Pfister, MAG PR at nina@mooringadvisorygroup.com

Contacts:

Nina Pfister
781-929-5620
nina@mooringadvisorygroup.com

Source: Cure Rare Disease

Distributed by: Reportable, Inc.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/69437